Retail Services & Systems, Inc. d/b/a Total Wine & More, FTC v.
Type of Action
Process Enforcement
Last Updated
Case Status
Pending
Displaying 241 - 260 of 4571
FTC Approves Final Order to Prevent Interlocking Directorate Arrangement, Anticompetitive Information Exchange in EQT, Quantum Energy Deal
Date
The Federal Trade Commission finalized a consent order that prevents entanglements and the exchange of confidential, competitively sensitive information to resolve antitrust concerns surrounding a $5...
QEP Partners/EQT Corporation, In the Matter of
Type of Action
Administrative
Last Updated
FTC Matter/File Number
2210212
Case Status
Pending
Axon Enterprise and Safariland, In the Matter of
The Federal Trade Commission issued an administrative complaint challenging Axon Enterprise, Inc.’s consummated acquisition of its body-worn camera systems competitor VieVu, LLC. Before the acquisition, the two companies competed to provide body-worn camera systems to large, metropolitan police departments across the United States. According to the complaint, Axon’s May 2018 acquisition reduced competition in an already concentrated market. Before their merger, Axon and VieVu competed to sell body-worn camera systems that were particularly well suited for large metropolitan police departments. The Commission vote to issue the administrative complaint was 5-0. On April 17, 2020, the Commission announced a proposed settlement with Safariland, which is one of the respondents and the parent company of VieVu. The final settlement was issued on June 11, 2020. The administrative trial was scheduled to begin on Oct. 13, 2020, but the United States Court of Appeals for the Ninth Circuit ordered a stay until further notice.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
1810162
Docket Number
9389
Case Status
Closed
FTC and DOJ to Co-Host October 5 Workshop on the 2023 Draft Merger Guidelines
Date
WHAT: The Federal Trade Commission and Justice Department are co-hosting a workshop to facilitate public dialogue on the 2023 Draft Merger Guidelines . The event is also co-hosted with the MIT...
FTC to Host Roundtable Discussion on October 4 on Artificial Intelligence and the Creative Fields
Date
WHAT: The Federal Trade Commission staff will be hosting a virtual roundtable discussion on October 4, 2023 to better understand the impact of the use of generative artificial intelligence on music...
FTC and DOJ Announce Additional Workshops on the 2023 Draft Merger Guidelines
Date
The Federal Trade Commission and Justice Department announced today that they plan to hold two additional workshops to facilitate public dialogue on the 2023 Draft Merger Guidelines that the agencies...
FTC Sues Amazon for Illegally Maintaining Monopoly Power
Date
The Federal Trade Commission and 17 state attorneys general today sued Amazon.com, Inc. alleging that the online retail and technology company is a monopolist that uses a set of interlocking...
FTC to Host Virtual Roundtable on AI and Content Creation
Date
The Federal Trade Commission staff will be hosting a virtual roundtable discussion on October 4, 2023 to better understand the impact of the use of generative artificial intelligence on music...
FTC Challenges Private Equity Firm’s Scheme to Suppress Competition in Anesthesiology Practices Across Texas
Date
The Federal Trade Commission today sued U.S. Anesthesia Partners, Inc. (USAP), the dominant provider of anesthesia services in Texas, and private equity firm Welsh, Carson, Anderson & Stowe, alleging...
U.S. Anesthesia Partners, Inc., FTC v.
Type of Action
Federal
Last Updated
FTC Matter/File Number
2010031
Case Status
Pending
FTC, Department of Labor Partner to Protect Workers from Anticompetitive, Unfair, and Deceptive Practices
Date
The Federal Trade Commission and the U.S. Department of Labor (DOL) signed a new agreement that will bolster the FTC’s efforts to protect workers by promoting competitive U.S. labor markets and...
FTC Issues Policy Statement on Brand Pharmaceutical Manufacturers’ Improper Listing of Patents in the Food and Drug Administration’s ‘Orange Book’
Date
The Federal Trade Commission today issued a policy statement , supported by the U.S. Food and Drug Administration (FDA), warning pharmaceutical companies that make and sell brand-name drugs that they...
Federal Trade Commission Statement Concerning Brand Drug Manufacturers' Improper Listing of Patents in the Orange Book
Date
Matter Number
P233900
File
Text of the Policy Statement
(633.47 KB)
Federal Register Notice
Amgen Inc. and Horizon Therapeutics plc; Analysis of Agreement Containing Consent Order To Aid Public Comment
Date
FTC Announces Tentative Agenda for September 14 Open Meeting
Date
Today, Federal Trade Commission Chair Lina M. Khan announced that an open meeting of the Commission will be held virtually on Thursday, September 14, 2023. The open meeting will commence at 11 a.m. ET...
Displaying 241 - 260 of 4571